Clinical Trial Update: Pathogenesis of Hematologic Malignancies

View source ↗

Summary

An update on an ongoing clinical trial exploring the pathogenesis of hematologic malignancies, with enrollment by invitation at the sponsor site.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoproliferative Disorders
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Acute Leukemia, Lymphoproliferative Disorders | Status: ENROLLING_BY_INVITATION